CME Stock Recent News

Here is how CME Group (CME) and Main Street Capital (MAIN) have performed compared to their sector so far this year.

Self-made millionaires build wealth through disciplined, consistent investing. I focus on dividend growth stocks, avoid single-stock risks, and live below my means to reinvest. I invest in wide-moat companies with strong fundamentals. Prioritizing dividend growth, I aim for income and long-term gains without timing the market. My picks reflect my conviction in dividend growth as a wealth-building tool. These stocks align with my long-term vision for financial security and success.

Forbes estimates Egerton Capital CIO John Armitage's net worth is $1.5 billion.

CME Group's near-monopoly in futures and options trading, with extraordinary 60% FCF margins, makes it a high-quality, capital-light business despite regulatory costs. Significant acquisitions like CBOT, NYMEX, and KCBT have solidified CME's market dominance, though future focus will be on dividends and smaller acquisitions. CME is slightly undervalued with a 4% dividend yield, making it a strong hold for dividend-focused investors seeking a high-quality business model.

CME Group has a dividend yield and a P/E ratio of 23.71, with a robust 10-year growth rate of 8%. The stock appears undervalued due to its strong balance sheet and market moat, presenting a potential buying opportunity. CME Group owns the world's largest derivatives exchanges, including CME, NYMEX, and COMEX, enhancing its market position.

Inflation remains stubborn, and the Fed's "higher for longer" stance favors value stocks. I'm doubling down on high-yield plays with strong cash flow and earnings to thrive in this environment. My top picks are resilient, wide-moat businesses that excel in uncertainty. Both offer market-beating yields, growth potential, and inflation-resistant business models. While risks like rate cuts exist, these stocks are built to deliver steady income and long-term gains, making them core holdings in my portfolio.

The Investment Committee give you their top stocks to watch for the second half.

Thank you to the Seeking Alpha community for your support! Reaching 40,000 followers is a dream come true. Your feedback fuels my work. I've invested 91% of my net worth in 23 high-conviction dividend stocks. Focused on wide-moat businesses, I prioritize quality and long-term growth over yield. My portfolio has outperformed the S&P 500, and I'm confident in its future. I expect a rotation to value stocks, and I'll keep sharing insights to grow together.

CME's quarterly results benefit from improving revenues, driven by higher clearing and transaction fees as well as market data and information services fees.

CME Group Inc. (NASDAQ:CME ) Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ET Company Participants Adam Minick - Investor Relations Terry Duffy - Chairman & Chief Executive Officer Lynne Fitzpatrick - Chief Financial Officer Julie Winkler - Chief Commercial Officer Derek Sammann - Global Head, Commodities Suzanne Sprague - Chief Operating Officer & Head, Risk and Clearing Tim McCourt - Global Head, Equities, FX & Alternative Products Mike Dennis - Global Head, Fixed Income Conference Call Participants Patrick Moley - Piper Sandler Alex Kramm - UBS Michael Cyprys - Morgan Stanley Benjamin Budish - Barclays Capital Chris Allen - Citi Dan Fannon - Jefferies Brian Bedell - Deutsche Bank Bill Katz - TD Cowen Owen Lau - Oppenheimer Kyle Voigt - KBW Madeline Daleiden - JPMorgan Simon Clinch - Redburn Atlantic Operator Welcome to the CME Group Fourth Quarter 2024 Earnings Call. At this time, I would like to inform all participants that your lines have been placed on a listen-only